For the quarter ending 2025-12-31, UPXI has $271,144,765 in assets.
| Balance Sheets | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash | 1,616,765 | 2,237,223 | 2,975,150 | |
| Accounts receivable, net | 594,552 | 284,261 | 157,515 | |
| Inventory, net | 728,273 | 1,035,680 | 1,152,870 | |
| Due from vitamedica transition | 304,880 | 471,380 | 228,017 | |
| Prepaid expenses and other receivables | 1,302,064 | 1,480,227 | 350,836 | |
| Current digital assets at fair value | 164,703,917 | 212,832,396 | 49,913,655 | |
| Assets available for sale - building | - | - | 0 | |
| Purchase price receivable - vitamedica | 2,000,000 | 2,000,000 | 2,000,000 | |
| Purchase price receivable - e-core | - | - | 0 | |
| Total current assets | 171,250,451 | 220,341,167 | 56,778,043 | |
| Property and equipment, net | 543,246 | 1,931,498 | 2,052,573 | |
| Intangible assets, net | 874,733 | 143,923 | 163,113 | |
| Goodwill | 673,854 | 848,854 | 848,854 | |
| Deferred tax asset | 5,948,858 | 5,948,858 | 5,948,858 | |
| Investment in digital company | - | 750,000 | - | |
| Digital assets at fair value, net of current | 90,998,464 | 187,993,435 | 56,083,525 | |
| Other assets | 218,710 | 200,690 | 192,123 | |
| Right-of-use asset, net | 636,449 | 1,569,742 | 1,739,755 | |
| Total other assets | 99,894,314 | 199,387,000 | 67,028,801 | |
| Total assets | 271,144,765 | 419,728,167 | 123,806,844 | |
| Accounts payable | 665,840 | 2,184,897 | - | |
| Accrued compensation | 3,111,115 | 3,176,969 | - | |
| Deferred revenue | 47,287 | 51,347 | - | |
| Accrued liabilities | 1,964,281 | 947,076 | - | |
| Accrued interest | 2,902,942 | 1,545,481 | - | |
| Acquisition payable | 260,652 | 260,652 | - | |
| Current portion of promissory notes | 560,000 | 560,000 | - | |
| Short-term treasury debt | 62,695,723 | 50,000,000 | - | |
| Current portion of cygnet subsidiary notes payable | 5,380,910 | 5,380,910 | - | |
| Current portion of operating lease payable | 263,672 | 521,702 | - | |
| Total current liabilities | 77,852,422 | 64,629,034 | - | |
| Operating lease payable, net of current portion | 460,134 | 1,145,439 | - | |
| Convertible notes payable | 144,115,480 | 143,161,862 | - | |
| Total long-term liabilities | 144,575,614 | 144,307,301 | - | |
| Preferred stock, 0.00001 par value, 10,000,000 shares authorized, and 150,000 and 150,000 shares issued and outstanding, respectively | 2 | 2 | - | |
| Common stock, 0.00001 par value, 1,000,000,000 shares authorized, 63,212,588 and 38,270,571 shares issued, as of december 31, 2025 and june 30, 2025, respectively | 632 | 589 | - | |
| Treasury stock, 416,226 and 0, as of december 31, 2025 and june 30, 2025, respectively | 799,277 | - | - | |
| Additional paid in capital | 222,236,002 | 204,586,941 | - | |
| Accumulated deficit | -172,720,630 | 6,204,300 | - | |
| Total stockholders' equity | 48,716,729 | 210,791,832 | - | |
| Total liabilities and stockholders' equity | 271,144,765 | 419,728,167 | 123,806,844 | |
UPEXI, INC. (UPXI)
UPEXI, INC. (UPXI)